Skip to main content
. 2010 Apr 27;33(7):1460–1462. doi: 10.2337/dc10-0310

Table 1.

Patient demographics and results

Dialysis Ulcer history Total
n 150 150 300
Male (%) 61 (40.7) 62 (41.3) 123 (41.0)
Race*
    White 116 (77.3) 64 (42.7) 180 (60.0)
    Black 20 (13.3) 54 (36.0) 74 (24.7)
    Hispanic 11 (7.3) 28 (18.6) 39 (13.0)
    Other 3 (2.0) 4 (2.7) 7 (2.3)
Age* 64.9 ± 0.98 74.25 ± 1.04 70.22 ± 0.58
Type 2 diabetes (%) 139 (92.6) 138 (92.0) 277 (92.3)
Amputation (%)* 22 (14.7) 5 (3.3) 27 (9)
Ulceration (%) 79 (52.7) 79 (52.7) 158 (52.6)
Neuropathy testing
    Semmes Weinstein monofilament 40 (26.7) 41 (27.3) 81 (27)
    Vibration perception threshold 4 (2.7) 3 (2.0) 7 (2.3)
    Other assessment 5 (3.3) 12 (8.0) 17 (5.7)
    No neuropathy testing 101 (67.3) 94 (62.7) 195 (65)
Vascular assessment
    Pedal pulse evaluated 71 (47.3) 84 (56.0) 155 (51.7)
    Ankle-brachial index evaluated 19 (12.7) 13 (8.7) 32 (10.7)
    No assessment 60 (40.0) 53 (35.3) 113 (37.6)
Diabetes education
    Session 1 (n) 1 (0.6) 0 1 (0.3)
    Session 2 (n) 1 (0.6) 0 1 (0.3)
    Sessions 3–4 0 0 0
Podiatry
    Podiatry (anytime)* 74 (49.3) 121 (80.6) 195 (65)
    Podiatry before an ulcer* 63 (42) 27 (18) 90 (30)
    Total podiatry visits 296 362 658
Therapeutic shoes and insoles
    Received shoes or insoles 11 (7.3) 10 (6.6) 21 (7.0)
    Received second shoes or insoles 1 (0.6) 3 (2.0) 4 (1.3)
    Received third shoes or insoles 0 0 0

Data are n (%) or means ± SE.

*P < 0.001.